tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
:NWPHF
US Market

Newron Pharmaceuticals SpA (NWPHF) Income Statement

Compare
9 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q4 2022), Newron Pharmaceuticals SpA's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Newron Pharmaceuticals SpA's net income was $―. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 4.96M$ 5.61M$ 2.65M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 134.00K$ 147.00K$ 155.00K$ 207.00K$ 47.00K
EBITDA
$ -13.32M$ -11.76M$ -17.16M$ -19.29M$ -14.44M
Operating Income
$ -13.30M$ -12.36M$ -18.07M$ -20.90M$ -14.98M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.49M$ -14.90M$ -21.00M$ -20.21M$ -15.04M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Newron Pharmaceuticals SpA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis